Tel: 01892 526726     Email:     Twitter

Broad and learned
clinical background

Gut Reactions #9 – New treatment for active ulcerative colitis (UC)

Tofacitinib is a new JAK inhibitor taken by mouth 10mg twice daily. Recent trials (OCTAVE) have shown significant benefit in patients with moderately active UC. The patients had previous failure or intolerance to conventional treatments. Patients receiving tofacitinib were significantly ...

Read more